The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms

  • End date
    Jun 30, 2022
  • participants needed
  • sponsor
    Yale University
Updated on 25 January 2021
gastrointestinal symptoms
gastroesophageal reflux


To prescribe oral domperidone for patients with upper GI symptoms who have failed or suffered adverse effects from standard medical therapy.


The primary objective of this study is to prescribe oral domperidone for patients with upper GI symptoms who have failed or suffered adverse effects from standard medical therapy

Condition Gastroparesis, Gastroparesis, Diabetic Gastroparesis, Gastropathy, Stomach Discomfort, Stomach Discomfort, Diabetic Gastroparesis, delayed gastric emptying, gastric atony
Treatment Domperidone
Clinical Study IdentifierNCT03810287
SponsorYale University
Last Modified on25 January 2021


Yes No Not Sure

Inclusion Criteria

Males or females who are 18 years of age or older
Symptoms or manifestations secondary to Gastro esophageal reflux disease (GERD) (e.g., persistent esophagitis, heartburn, upper airway signs or symptoms or respiratory symptoms), gastrointestinal motility disorders such as nausea, vomiting, severe dyspepsia or severe chronic constipation that are refractory to standard therapy

Exclusion Criteria

i. History of, or current, arrhythmias including ventricular tachycardia, ventricular fibrillation and Torsade des Pointes. Patients with minor forms of ectopy (PACs) are not necessarily excluded
ii. Clinically significant bradycardia, sinus node dysfunction, or heart
iii. Prolonged QTc (QTc>450 milliseconds for males, QTc>470 milliseconds for
iv. Clinically significant electrolyte disorders
\. Gastrointestinal hemorrhage or obstruction
\. Presence of a prolactinoma (prolactin-releasing pituitary tumor)
\. Pregnant or breast feedings female
\. Known allergy to domperidone
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note